Root Financial Partners’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.47K Buy
+341
New +$1.99K ﹤0.01% 2781
2026
Q2
– Sell
-58
Closed -$466 – 2786
2026
Q1
$466 Buy
+58
New +$556 ﹤0.01% 2888

Other funds holding SPRY

Root Financial Partners's SPRY Position: Q3 2026 in Review

Root Financial Partners opened a new position in ARS Pharmaceuticals (SPRY) in Q3 2026: 341 shares worth $1.47K. The stake represents ﹤0.01% of the portfolio and ranks #2781 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in SPRY as recently as Q1 2026.

Root Financial Partners first reported a position in SPRY in Q1 2026 and has held it in 2 quarters since. 190 funds tracked by Wall St. Rank hold SPRY as of Q3 2026.

  • Root Financial Partners held 341 shares of ARS Pharmaceuticals worth $1.47K as of Q3 2026.
  • ARS Pharmaceuticals was a new Root Financial Partners position in Q3 2026.
  • ARS Pharmaceuticals made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #2781 holding.
  • Root Financial Partners first reported a position in ARS Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 190 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.